Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Michael P Bogenschutz"'
Autor:
Christina Marini, Nicole S Northover, Noah D Gold, Ursula K Rogers, Kelley C O’Donnell, Babak Tofighi, Stephen Ross, Michael P Bogenschutz
Publikováno v:
Substance Abuse: Research and Treatment, Vol 17 (2023)
Objective: The timeline followback (TLFB) interview is the gold standard for the quantitative assessment of alcohol use. However, self-reported “drinks” can vary in alcohol content. If this variability is not accounted for, it can compromise the
Externí odkaz:
https://doaj.org/article/65fe23ccb98446a2bc834de21acad0f2
Autor:
Amber Regis, Sarah E. Meyers-Ohki, Sarah E. Mennenga, Peter P. Greco, Richard Glisker, Rhonda Kolaric, Ryan P. McCormack, Richard C. Rapp, Michael P. Bogenschutz
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-14 (2020)
Abstract Background As the USA grapples with an opioid epidemic, medical emergency departments (EDs) have become a critical setting for intervening with opioid-dependent patients. Brief interventions designed to bridge the gap from acute ED care to l
Externí odkaz:
https://doaj.org/article/18be0d64349e42918c9b86a9d1c5a931
Autor:
Noah D. Gold, Austin J. Mallard, Jacob C. Hermann, Richard J. Zeifman, Broc A. Pagni, Michael P. Bogenschutz, Stephen Ross
Publikováno v:
Journal of Palliative Medicine.
Autor:
Noah D. Gold, Samantha K. Podrebarac, Lindsay A. White, Christina Marini, Naomi M. Simon, Mary S. Mittelman, Stephen Ross, Michael P. Bogenschutz, Petros D. Petridis
Publikováno v:
Psychedelic Medicine.
Autor:
Brian D. Kiluk, Bethea A. Kleykamp, Sandra D. Comer, Roland R. Griffiths, Andrew S. Huhn, Matthew W. Johnson, Kyle M. Kampman, Marco Pravetoni, Kenzie L. Preston, Ryan Vandrey, Cecilia L. Bergeria, Michael P. Bogenschutz, Randall T. Brown, Kelly E. Dunn, Robert H. Dworkin, Patrick H. Finan, Peter S. Hendricks, Elisabeth J. Houtsmuller, Thomas R. Kosten, Dustin C. Lee, Frances R. Levin, Aimee McRae-Clark, Charles L. Raison, Kurt Rasmussen, Dennis C. Turk, Roger D. Weiss, Eric C. Strain
Publikováno v:
JAMA psychiatry. 80(1)
ImportanceNovel treatments for opioid use disorder (OUD) are needed to address both the ongoing opioid epidemic and long-standing barriers to existing OUD treatments that target the endogenous μ-opioid receptor (MOR) system. The goal of this review
Autor:
Paulo Cesar Ribeiro Barbosa, Luís F. Tófoli, Michael P. Bogenschutz, Robert Hoy, Lais F. Berro, Eduardo A. V. Marinho, Kelsy N. Areco, Michael J. Winkelman
Publikováno v:
Frontiers in Psychiatry, Vol 9 (2018)
The aims of this study were to assess the impact of ceremonial use of ayahuasca—a psychedelic brew containing N,N-dimethyltryptamine (DMT) and β-carboline —and attendance at União do Vegetal (UDV) meetings on substance abuse; here we report the
Externí odkaz:
https://doaj.org/article/714feb4088cc40c9bcaa248abdef9a08
Autor:
Tara C. Malone, Sarah E. Mennenga, Jeffrey Guss, Samantha K. Podrebarac, Lindsey T. Owens, Anthony P. Bossis, Alexander B. Belser, Gabrielle Agin-Liebes, Michael P. Bogenschutz, Stephen Ross
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
A growing body of evidence shows that existential and spiritual well-being in cancer patients is associated with better medical outcomes, improved quality of life, and serves as a buffer against depression, hopelessness, and desire for hastened death
Externí odkaz:
https://doaj.org/article/91ab5d5392744257914be4ff8a4c8766
Autor:
Michael P. Bogenschutz, Samantha K. Podrebarac, Jessie H. Duane, Sean S. Amegadzie, Tara C. Malone, Lindsey T. Owens, Stephen Ross, Sarah E. Mennenga
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
After a hiatus of some 40 years, clinical research has resumed on the use of classic hallucinogens to treat addiction. Following completion of a small open-label feasibility study, we are currently conducting a double-blind placebo-controlled clinica
Externí odkaz:
https://doaj.org/article/962c073a97be438aa267398cdbf21788
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Research on the clinical applications of psychedelic-assisted psychotherapy has demonstrated promising early results for treatment of alcohol dependence. Detailed description of the content and methods of psychedelic-assisted psychotherapy, as it is
Externí odkaz:
https://doaj.org/article/f8ec58ac1d994748a77322530cec8806
Autor:
Michael P. Bogenschutz, Kjeld Andersen, Gerhard Bühringer, Anette Søgaard Nielsen, Alexis Kuerbis, Silke Behrendt, Randi Bilberg, Anna Mejldal, Barbara Braun-Michl
Publikováno v:
Behrendt, S, Kuerbis, A, Braun-Michl, B, Bilberg, R, Bühringer, G, Bogenschutz, M, Mejldal, A, Andersen, K & Nielsen, A S 2021, ' Residual alcohol use disorder symptoms after treatment predict long-term drinking outcomes in seniors with DSM-5 alcohol use disorder ', Alcoholism: Clinical and Experimental Research, vol. 45, no. 11, pp. 2396-2405 . https://doi.org/10.1111/acer.14722
Background: Risk of relapse within the first months after alcohol use disorder (AUD) interventions is substantial among older adults. For this vulnerable group, little information exists on how this risk is associated with residual DSM-5 AUD symptoms